AGÕæÈ˹ٷ½

STOCK TITAN
  1. Home
  2. Sec-filings
  3. MOLN
  4. [SCHEDULE 13G] Molecular Partners AG American SEC Filing

[SCHEDULE 13G] Molecular Partners AG American SEC Filing

Filing Impact
(Low)
Filing Sentiment
(Neutral)
Form Type
SCHEDULE 13G

Filing content is currently unavailable.

Source:

Stock MOLN logo
MOLECULAR PARTNERS AG

NASDAQ:MOLN

MOLN Rankings

#4523 Ranked by Market Cap
N/A Ranked by Dividends

MOLN Latest News

Aug 21, 2025
Molecular Partners appoints Martin Steegmaier as Chief Scientific Officer to drive discovery of next-gen DARPin therapeutics
Jun 22, 2025
Molecular Partners and Orano Med present preclinical data on mesothelin-targeting Radio-DARPin candidate MP0726 at SNMMI 2025
Jun 11, 2025
Molecular Partners presents positive data from ongoing Phase 1/2a trial of MP0533 in AML at EHA 2025
Jun 10, 2025
Molecular Partners Announces Planned Operational Efficiencies and Extension of Cash Runway
May 19, 2025
Molecular Partners to Present at Upcoming Investor Conferences

MOLN Latest SEC Filings

Jun 25, 2025
[S-8] Molecular Partners AG American Employee Benefit Plan Registration

MOLN Stock Data

127.96M
36.86M
9.73%
0.09%
Biotechnology
Healthcare
Switzerland
Schlieren